Home › Companies › UNCY

Unicycive Therapeutics

UNCY Lead: NDA Submitted 1 Biotech Distilled article ↓

Renal Small Molecule

Most recent annual filing: 2026-03-30

Pipeline (2 active programs)

Renalan

oxylanthanum carbonate · lanthanum dioxycarbonate · OLC · RZB 012 · SPI 014

Hyperphosphatemia NDA Submitted oral

UNI-494

Small Molecule Target: SUR2B, mitochondrial KATP channel

Delayed Graft Function Phase 1 oral

Biotech Distilled coverage (1)

2026-06-26 Unicycive Therapeutics (UNCY) - Scientific Deep Dive for Oxylanthanum Carbonate (OLC) and Pipeline Products

Articles open on Substack. Some deep dives are subscriber-only.